Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium + Tropisetron for Postoperative Nausea and Vomiting
NCT05331651Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glycopyrronium in postoperative nausea and vomiting (PONV) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Incidence of postoperative nausea and vomiting at 24 hours. Started Apr 2022; status: completed.
02
Drugs
glycopyrronium
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05331651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331651.